CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
CNBX Pharmaceuticals Inc.
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $197.79K
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 12, 2022 | 1-for-120 reverse | Earlier per-share figures multiplied by 120 |
| Jul 14, 2014(first seen in filings) | 2-for-1 | Earlier per-share figures divided by 2 |
| Jun 30, 2014 | 2-for-1 | Earlier per-share figures divided by 2 |
| Sep 30, 2010 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |